significant advantages of this agent over other currently available radiopharmaceuticals include : a ) a broader spectrum of tumors taking up the radio-pharmaceutical , and b ) generally better delineation of abdominal and pelvic disease due to lack of interference from gut uptake .
C0027651
tumors
C0012634
disease